Is insulin resistance atherogenic? A review of the evidence

被引:18
作者
Ferrannini, Ele [1 ]
Iozzo, Patricia [1 ]
机构
[1] Dept Internal Med, I-56126 Pisa, Italy
关键词
antherogenic; cardiovascular disease; insulin resistance;
D O I
10.1016/j.atherosclerosissup.2006.05.006
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several factors that increase the risk of cardiovascular disease tend to cluster together in the same individual. Insulin resistance is believed to be a pathophysiological disturbance that underlies many of the risk factors. Whether insulin resistance per se is a cardiovascular risk factor is uncertain. Insulin resistance of myocardial muscle has been documented both in patients with type 2 diabetes and in nondiabetic subjects with angiographically proven coronary artery disease. In addition, in diabetic patients there is a mismatch between the redistribution of blood flow and glucose uptake during insulinization. Finally, the endothelial dysfunction and the hyperinsulinemia that accompany insulin resistance may adversely affect myocardial function. The evidence from epidemiological studies or clinical trials is, however, mixed. In at least one recent prospective study in patients with congestive heart failure, insulin resistance was an independent predictor of cardiac death. Conclusive proof would require a prospective study in which insulin resistance is measured directly and adequate account is taken of the classical cardiovascular risk factors. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 25 条
[21]   Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians - The Strong Heart Study [J].
Resnick, HE ;
Jones, K ;
Ruotolo, G ;
Jain, AK ;
Henderson, J ;
Lu, WQ ;
Howard, BV .
DIABETES CARE, 2003, 26 (03) :861-867
[22]   Insulin resistance and cardiovascular events with low HDL cholesterol - The Veterans Affairs HDL Intervention Trial (VA-HIT) [J].
Robins, SJ ;
Rubins, HB ;
Faas, FH ;
Schaefer, EJ ;
Elam, MB ;
Anderson, JW ;
Collins, D .
DIABETES CARE, 2003, 26 (05) :1513-1517
[23]   Diabetes, plasma insulin, and cardiovascular disease - Subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT) [J].
Rubins, HB ;
Robins, SJ ;
Collins, D ;
Nelson, DB ;
Elam, MB ;
Schaefer, EJ ;
Faas, FH ;
Anderson, JW .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (22) :2597-2604
[24]   EFFECT OF FREE FATTY-ACIDS ON MYOCARDIAL OXYGEN-CONSUMPTION DURING ATRIAL-PACING AND CATECHOLAMINE INFUSION IN MAN [J].
SIMONSEN, S ;
KJEKSHUS, JK .
CIRCULATION, 1978, 58 (03) :484-491
[25]   Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? [J].
Stern, MP ;
Williams, K ;
González-Villalpando, C ;
Hunt, KJ ;
Haffner, SM .
DIABETES CARE, 2004, 27 (11) :2676-2681